Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Tenchusatsu who wrote (1376849)	10/12/2022 9:13:12 PM
From: Wharf Rat	Read Replies (2) \| Respond to of 1583672

Thanks; that's almost perfect, but I'd say the Ukraine invasion was more like Hitler's Sudatenland takeover than Poland... Never heard of "Hitler reacts".

To: Tenchusatsu who wrote (1376849)	10/12/2022 10:05:47 PM
From: Broken_Clock	Respond to of 1583672

Tenshtsyou thinks Big Pharma and the gov't are to be relied upon...because...they are SO honest and have our best interests in mind. That's why WE MUST RELY ON and OBEY them! zerohedge.com +++ Thousands Of US Officials Trade Shares Of Companies They Regulate: WSJ by Tyler Durden Wednesday, Oct 12, 2022 - 03:45 PM More than 2,600 executive branch officials have bought and sold shares of companies whose fortunes rise and fall on the policies their agencies enact,* a Wall Street Journal investigation has found. While controversy about insider trading by members of Congress has occasionally stirred major headlines, this phenomenon has quietly endured across Democratic and Republican administrations alike -- and it involves more than 20% of senior officials among the 50 agencies covered by the Journal's research so far. The findings are based on the Journal's study of more than 31,000 disclosure forms filed between 2016 and 2021 by 12,000 senior career employees, presidential appointees and political staffers. Some riskier trades -- involving options and short sales, for example -- were valued between $5 million and $25 million. Though it's illegal for officials to work on issues in which they have a direct financial interest -- and though regulations even prohibit the mere appearance of conflicts of interest -- the Journal found many such instances. For example: "A top official at the Environmental Protection Agency reported purchases of oil and gas stocks. The Food and Drug Administration improperly let an official own dozens of food and drug stocks on its no-buy list. A Defense Department official bought stock in a defense company five times before it won new business from the Pentagon." Often, ethics officials have simply waived the rules, or certified that an official's trade qualifies for an exception. More than 40% of the Treasury Department's senior officials traded in companies touched by their agency -- the highest among the 50 agencies studies by the Journal. Treasury was followed by the Environmental Protection Agency, the Department of Defense, the IRS, SEC and the Fed -- each of which had an above-average percentage of officials implicated. *Some agencies sought to thwart the Journal's scrutiny, and at least one is still stonewalling completely: "Some [agencies] made it difficult to obtain the forms, and several agencies haven’t turned over all of them. The Department of Homeland Security hasn’t provided any financial records," the Journal* reports. The Journal has indicated these initial revelations are just the start of an investigative series. For a deep dive into several examples of questionable trading by federal officials, read the Journal's first installment here.